 Oligodeoxyribonucleotides, Antisense
"Oligodeoxyribonucleotides, Antisense" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Short fragments of DNA that are used to alter the function of target RNAs or DNAs to which they hybridize.
| Descriptor ID |
D020319
|
| MeSH Number(s) |
D13.150.200.640 D13.150.480.640 D13.444.308.150.640 D13.444.600.150.200.640 D13.444.600.150.640.640 D13.695.578.424.480.640 D27.720.470.530.600.150.200.640 D27.720.470.530.600.150.640.640
|
| Concept/Terms |
Oligodeoxyribonucleotides, Antisense- Oligodeoxyribonucleotides, Antisense
- Antisense Oligodeoxyribonucleotides
- Antisense OligoDNA
- OligoDNA, Antisense
- Anti-Sense Oligodeoxyribonucleotides
- Anti Sense Oligodeoxyribonucleotides
- Oligodeoxyribonucleotides, Anti-Sense
- Oligodeoxyribonucleotide, Antisense
- Antisense Oligodeoxyribonucleotide
|
Below are MeSH descriptors whose meaning is more general than "Oligodeoxyribonucleotides, Antisense".
- Chemicals and Drugs [D]
- Nucleic Acids, Nucleotides, and Nucleosides [D13]
- Antisense Elements (Genetics) [D13.150]
- DNA, Antisense [D13.150.200]
- Oligodeoxyribonucleotides, Antisense [D13.150.200.640]
- Oligonucleotides, Antisense [D13.150.480]
- Oligodeoxyribonucleotides, Antisense [D13.150.480.640]
- Nucleic Acids [D13.444]
- DNA [D13.444.308]
- DNA, Antisense [D13.444.308.150]
- Oligodeoxyribonucleotides, Antisense [D13.444.308.150.640]
- Nucleic Acid Probes [D13.444.600]
- Antisense Elements (Genetics) [D13.444.600.150]
- DNA, Antisense [D13.444.600.150.200]
- Oligodeoxyribonucleotides, Antisense [D13.444.600.150.200.640]
- Oligonucleotides, Antisense [D13.444.600.150.640]
- Oligodeoxyribonucleotides, Antisense [D13.444.600.150.640.640]
- Nucleotides [D13.695]
- Polynucleotides [D13.695.578]
- Oligonucleotides [D13.695.578.424]
- Oligonucleotides, Antisense [D13.695.578.424.480]
- Oligodeoxyribonucleotides, Antisense [D13.695.578.424.480.640]
- Chemical Actions and Uses [D27]
- Specialty Uses of Chemicals [D27.720]
- Laboratory Chemicals [D27.720.470]
- Molecular Probes [D27.720.470.530]
- Nucleic Acid Probes [D27.720.470.530.600]
- Antisense Elements (Genetics) [D27.720.470.530.600.150]
- DNA, Antisense [D27.720.470.530.600.150.200]
- Oligodeoxyribonucleotides, Antisense [D27.720.470.530.600.150.200.640]
- Oligonucleotides, Antisense [D27.720.470.530.600.150.640]
- Oligodeoxyribonucleotides, Antisense [D27.720.470.530.600.150.640.640]
Below are MeSH descriptors whose meaning is more specific than "Oligodeoxyribonucleotides, Antisense".
This graph shows the total number of publications written about "Oligodeoxyribonucleotides, Antisense" by people in this website by year, and whether "Oligodeoxyribonucleotides, Antisense" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 | | 1996 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 2000 | 1 | 1 | 2 | | 2001 | 2 | 0 | 2 | | 2003 | 2 | 1 | 3 | | 2004 | 0 | 1 | 1 | | 2007 | 0 | 1 | 1 | | 2016 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Oligodeoxyribonucleotides, Antisense" by people in Profiles.
-
McNally EM, Wyatt EJ. Welcome to the splice age: antisense oligonucleotide-mediated exon skipping gains wider applicability. J Clin Invest. 2016 Apr 01; 126(4):1236-8.
-
Isogai S, Athiviraham A, Fraser RS, Taha R, Hamid Q, Martin JG. Interferon-gamma-dependent inhibition of late allergic airway responses and eosinophilia by CD8+ gammadelta T cells. Immunology. 2007 Oct; 122(2):230-8.
-
Vohra BP, Groshong JS, Maselli RA, Verity MA, Wollmann RL, Gomez CM. Focal caspase activation underlies the endplate myopathy in slow-channel syndrome. Ann Neurol. 2004 Mar; 55(3):347-52.
-
Liang X, Lu L, Chen Z, Vickers T, Zhang H, Fung JJ, Qian S. Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival. Transplantation. 2003 Aug 27; 76(4):721-9.
-
Okabe H, Satoh S, Furukawa Y, Kato T, Hasegawa S, Nakajima Y, Yamaoka Y, Nakamura Y. Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res. 2003 Jun 15; 63(12):3043-8.
-
Chen Z, Lu L, Zhang H, Dean NM, Fung JJ, Qian S. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity. Microsurgery. 2003; 23(5):494-7.
-
Rudin CM, Holmlund J, Fleming GF, Mani S, Stadler WM, Schumm P, Monia BP, Johnston JF, Geary R, Yu RZ, Kwoh TJ, Dorr FA, Ratain MJ. Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer. Clin Cancer Res. 2001 May; 7(5):1214-20.
-
Liang X, Lu L, Zhang H, Vickers T, Fung JJ, Qian S. Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA. Transplant Proc. 2001 Feb-Mar; 33(1-2):235.
-
Xu J, Love LM, Singh I, Zhang QX, Dewald J, Wang DA, Fischer DJ, Tigyi G, Berthiaume LG, Waggoner DW, Brindley DN. Lipid phosphate phosphatase-1 and Ca2+ control lysophosphatidate signaling through EDG-2 receptors. J Biol Chem. 2000 Sep 08; 275(36):27520-30.
-
Mata JE, Bishop MR, Tarantolo SR, Angel CR, Swanson SA, Iversen PL. Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment. J Toxicol Clin Toxicol. 2000; 38(4):383-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|